173 related articles for article (PubMed ID: 25217658)
1. High levels of tobacco-specific N-nitrosamines and nicotine in Chaini Khaini, a product marketed as snus.
Stepanov I; Gupta PC; Dhumal G; Yershova K; Toscano W; Hatsukami D; Parascandola M
Tob Control; 2015 Dec; 24(e4):e271-4. PubMed ID: 25217658
[TBL] [Abstract][Full Text] [Related]
2. Tobacco-specific nitrosamines in smokeless tobacco products marketed in India.
Stepanov I; Hecht SS; Ramakrishnan S; Gupta PC
Int J Cancer; 2005 Aug; 116(1):16-9. PubMed ID: 15756678
[TBL] [Abstract][Full Text] [Related]
3. Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus.
Stepanov I; Jensen J; Biener L; Bliss RL; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Oct; 14(10):1241-5. PubMed ID: 22259150
[TBL] [Abstract][Full Text] [Related]
4. Assessment of mouth-level exposure to tobacco constituents in U.S. snus consumers.
Caraway JW; Chen PX
Nicotine Tob Res; 2013 Mar; 15(3):670-7. PubMed ID: 22990227
[TBL] [Abstract][Full Text] [Related]
5. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
[TBL] [Abstract][Full Text] [Related]
6. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
[TBL] [Abstract][Full Text] [Related]
7. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
8. Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.
Stepanov I; Biener L; Knezevich A; Nyman AL; Bliss R; Jensen J; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Mar; 14(3):274-81. PubMed ID: 22039075
[TBL] [Abstract][Full Text] [Related]
9. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
[TBL] [Abstract][Full Text] [Related]
10. Chemical analysis of snus products from the United States and northern Europe.
Lawler TS; Stanfill SB; Tran HT; Lee GE; Chen PX; Kimbrell JB; Lisko JG; Fernandez C; Caudill SP; deCastro BR; Watson CH
PLoS One; 2020; 15(1):e0227837. PubMed ID: 31940415
[TBL] [Abstract][Full Text] [Related]
11. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines.
Stanfill SB; Connolly GN; Zhang L; Jia LT; Henningfield JE; Richter P; Lawler TS; Ayo-Yusuf OA; Ashley DL; Watson CH
Tob Control; 2011 May; 20(3):e2. PubMed ID: 21109685
[TBL] [Abstract][Full Text] [Related]
12. Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.
Gray JN; Breland AB; Weaver M; Eissenberg T
Nicotine Tob Res; 2008 Sep; 10(9):1441-8. PubMed ID: 19023835
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of Harmful Constituent Profiles in Smokeless Tobacco Products from Five African Countries.
Gomez F; Ayo-Yusuf O; Yershova K; Jain V; Alcheva A; Hatsukami DK; Parascandola M; Stepanov I
Chem Res Toxicol; 2023 Dec; 36(12):1901-1911. PubMed ID: 38051542
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P; Hodge K; Stanfill S; Zhang L; Watson C
Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
[TBL] [Abstract][Full Text] [Related]
15. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches.
Mallock N; Schulz T; Malke S; Dreiack N; Laux P; Luch A
Tob Control; 2024 Feb; 33(2):193-199. PubMed ID: 38378209
[TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of harmful and potentially harmful constituents, pH, and moisture content in 16 commercial smokeless tobacco products.
Edwards SH; Hassink MD; Taylor KM; Vu AT
Regul Toxicol Pharmacol; 2022 Aug; 133():105199. PubMed ID: 35662636
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tobacco-specific nitrosamine levels in smokeless tobacco products: High levels in products from Bangladesh.
Nasrin S; Chen G; Watson CJW; Lazarus P
PLoS One; 2020; 15(5):e0233111. PubMed ID: 32453764
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
[TBL] [Abstract][Full Text] [Related]
19. Grass roots approach to control levels of carcinogenic nitrosamines, NNN and NNK in smokeless tobacco products.
Gupta AK; Tulsyan S; Bharadwaj M; Mehrotra R
Food Chem Toxicol; 2019 Feb; 124():359-366. PubMed ID: 30543893
[TBL] [Abstract][Full Text] [Related]
20. Characterization of physiochemical parameters & their effect on microbial content of smokeless tobacco products marketed in north India.
Shahid M; Srivastava S; Shukla P; Yadav R; Sajid M; Kumar A; Singh S; Bharadwaj M
Indian J Med Res; 2023 Nov; 158(5&6):542-551. PubMed ID: 38088421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
